Middle East And Africa Nucleic Acid Isolation Purification Market
Market Size in USD Million
CAGR :
% 
USD
225.03 Million
USD
396.75 Million
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 225.03 Million |
 Market Size (Forecast Year) |
USD 396.75 Million |
 CAGR |
% |
| Major Markets Players |
|
Middle East and Africa Nucleic Acid Isolation and Purification Market, By Product (Instruments, Kits, and Reagents), Method (Magnetic Bead-Based Isolation and Purification, Column -Based Isolation and Purification, Reagent-Based Isolation and Purification, and Others), Type (Next Generation Sequencing (NGS), Genomic DNA Isolation and Purification, Total RNA Isolation and Purification, PCR Clean-Up, Plasmid DNA Isolation and Purification, Messenger RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, MicroRNA Isolation and Purification, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Others), Sample Type (FFPE Samples, Blood Cells, Bacteria, Yeast, and Plants, Cell-Free Samples, Cultured Cells, Mammalian Cells, and Brain and Kidney Tissue, and Others), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Contract Development and manufacturing Organization (CDMO), Academic/Research Institutes, and Others) - Industry Trends and Forecast to 2032
Nucleic Acid Isolation and Purification Market Size
- The Middle East and Africa nucleic acid isolation and purification market was valued at USD 225.02 Million in 2024 and is expected to reach USD 396.75 Million by 2032
- During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.0%, primarily driven by the anticipated launch of new treatment devices
- This growth is driven by factors such as the increasing prevalence of genetic disorders, particularly in developing countries, drives the demand for increasing demand for diagnostic testing
Nucleic Acid Isolation and Purification Analysis
- The increasing demand for nucleic acid-based diagnostics, personalized medicine, and biopharmaceutical research has significantly driven the need for efficient nucleic acid isolation and purification technologies
- In addition, advancements in automation, magnetic bead-based separation, and microfluidic platforms are enhancing the speed, yield, and accuracy of nucleic acid extraction, supporting high-throughput applications in clinical and research settings
- For instance, the market for nucleic acid isolation and purification shows notable growth in regions like Asia-Pacific, where expanding biotech sectors and increased R&D funding are accelerating technology adoption
- In conclusion, the convergence of growing application areas and continuous innovation in isolation techniques is fostering robust market expansion, enabling improved molecular diagnostics, drug discovery, and genomic research globally
Report Scope and Nucleic Acid Isolation and Purification Segmentation
|
Attributes |
Nucleic Acid Isolation and Purification Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Nucleic Acid Isolation and Purification Market Trends
“Growing Applications of Liquid Biopsy In Non-Invasive Diagnostics”
- Liquid biopsy, which analyzes circulating nucleic acids (DNA, RNA, exosomes) in bodily fluids such as blood, enables early detection, monitoring, and personalized treatment of various diseases, particularly cancer.
- The complexity of extracting high-quality nucleic acids from these diverse and often fragmented samples requires advanced isolation and purification technologies
- For instance, Liquid biopsy, combined with high-throughput omics technologies, is transforming disease management through non-invasive, personalized diagnostics. Expanding use across diverse biofluids and integration into clinical practice highlight its growing utility. Standardization, improved protocols, and biomarker discovery are driving nucleic acid purification advancements, enabling more accurate, accessible, and individualized patient care
- The rise of liquid biopsy as a non-invasive diagnostic tool offers significant opportunities for the nucleic acid isolation and purification market.
- As liquid biopsy is increasingly used for early disease detection and treatment monitoring, there is a growing need for advanced purification technologies capable of extracting high-quality nucleic acids from complex biological fluids.
Nucleic Acid Isolation and Purification Market Dynamics
Driver
“Rising Investment in Genomics Research”
- The influx of funding from governments, private sectors, and research institutions worldwide has intensified the need for reliable and high-quality nucleic acid isolation to support large-scale sequencing projects, gene editing, biomarker discovery, and personalized medicine initiatives.
- This investment boosts demand for efficient and accurate purification systems that ensure DNA and RNA samples meet the quality required for advanced applications like CRISPR, Next-Generation Sequencing (NGS), and other genomic tools
- As research expands, so does the requirement for scalable, high-throughput isolation methods, reinforcing market growth and driving innovation in nucleic acid purification technologies
For instance,
- In December 2022, as per BMJ, the government was planning to invest more than USD 190.54 million into improving the diagnosis of rare genetic diseases in newborns, improving cancer diagnoses, and tackling health inequalities as part of its three-year plan. As investment increases, there are new innovations in this field that act as drivers of market growth
- In September 2023, according to NHGRI, the National Human Genome Research Institute (NHGRI) accelerates genomics research by funding and collaborating with scientists across government, public, and private institutions. Through initiatives like the All of Us Research Program and ENCODE, NHGRI supports research on genetic variations and their impact on health. Partnerships extend to technology advancements in sequencing and data analysis, enhancing genomic tools and knowledge-sharing. This collaborative approach aims to drive breakthroughs in precision medicine and public health
- Increased investment in genomics research propels the nucleic acid isolation and purification market, as more funding supports advanced genetic studies and the development of targeted treatments
- This demand for high-quality DNA and RNA purification grows with expanded applications like NGS and CRISPR, creating a need for scalable, efficient isolation solutions to support cutting-edge genomics
Opportunity
“Rise In Technological Advancements and Automation”
- Technological innovations such as fully automated extraction systems, high-throughput sequencing, and microfluidics are enhancing accuracy, speed, and scalability in genetic research and diagnostics
- By reducing manual intervention, these advancements minimize human error and improve consistency in sample processing. They cater to the growing demand in genomics, proteomics, and personalized medicine by enabling labs to process larger sample volumes with precision and efficiency
For instance,
- In December 2023, as per Technology Networks, Thermo Fisher Scientific Inc., a global leader in scientific services, has launched the Thermo Scientific KingFisher Apex Dx, an automated nucleic acid purification instrument, along with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit. These products work together to enable the isolation and purification of viral and bacterial pathogens from respiratory samples. Designed for In Vitro Diagnostic (IVD) and In Vitro Diagnostic Regulation (IVD-R) compliance, these automated solutions provide laboratories with enhanced reliability for downstream testing results
- In November 2023, Elsevier highlighted that, the development of RNA/DNA automated extraction and purification devices for infectious disease diagnosis signifies a pivotal advancement in biotechnology, highlighting the rise in technological innovations and automation within the field. These devices streamline complex laboratory workflows, enabling rapid and precise sample processing that is crucial for accurate diagnosis, especially during disease outbreaks. Technological advancements have led to more compact, efficient, and user-friendly systems, reducing manual intervention and enhancing throughput and reliability. Automation not only minimizes errors but also increases the speed of diagnostic processes, supporting timely clinical decisions and improving patient outcomes. The integration of these advanced technologies is transforming diagnostics, making them more accessible, scalable, and adaptable to various healthcare settings
- The rapid advancements in technology and automation are transforming the nucleic acid isolation and purification market by boosting accuracy, efficiency, and integration with downstream processes
- These innovations enable labs to meet growing demand across genomics, diagnostics, and personalized medicine with higher throughput and reduced costs. As these technologies become more widely accessible, they expand research and diagnostic capabilities, driving broader adoption in labs and institutions worldwide, ultimately accelerating progress across numerous scientific and medical fields
Restraint/Challenge
“Technical Difficulties in Nucleic Acid Isolation Across Different Sample Types”
- Different sample sources, such as blood, tissue, urine, and saliva, present unique challenges due to the varying levels of nucleic acid concentrations, the presence of inhibitors, and the complexity of the biological matrix
- Blood samples may contain low amounts of circulating free DNA or RNA, while tissue samples can be more challenging due to the high levels of contaminants and cellular components that interfere with nucleic acid extraction
- Also, certain samples, like those from formalin-fixed paraffin-embedded tissues, require specialized methods to prevent degradation or loss of nucleic acids during the isolation process
For instance,
- In September 2020, article published by APOS stated, biological samples such as saliva or urine contain low concentrations of nucleic acids, requiring highly sensitive protocols to ensure accurate extraction. Tissues, particularly those with high levels of proteins or lipids, often present obstacles in separating pure nucleic acids without contamination. Also, samples like FFPE tissues are subjected to formalin fixation, which cross-links nucleic acids and makes extraction more difficult. However, overcoming the inherent complexities of different sample types remains a critical focus for future developments, ensuring that nucleic acid extraction and isolation methods are adaptable, efficient, and scalable for a broad range of clinical and research applications
- In September 2020,as per Complex sample matrices often contain inhibitors that interfere with nucleic acid amplification, reducing test sensitivity and reliability. Effective lysis and extraction methods must avoid these inhibitors while remaining compatible with simplified workflows. Balancing performance with portability is essential for adapting nucleic acid purification processes to field-ready, point-of-need diagnostic platforms
- Technical challenges in isolating nucleic acids from various sample types, such as blood, tissue, and urine, create obstacles in the nucleic acid purification market
- These samples often present low nucleic acid yields, inhibitors, or complex biological matrices, requiring specialized methods for effective extraction
Middle East and Africa Nucleic Acid Isolation and Purification Market Scope
Middle East and Africa Nucleic Acid Isolation and Purification market is categorized into five notable segments the basis of product, method, type, sample type and end user.
|
Segmentation |
Sub-Segmentation |
|
BY PRODUCT |
|
|
BY METHOD |
|
|
BY TYPE |
|
|
BY SAMPLE TYPE |
|
|
BY END USER |
|
Middle East and Africa Nucleic Acid Isolation and Purification Market Regional Analysis
“South Africa is the Dominant country in the Nucleic Acid Isolation and Purification Market”
- South Africa is the dominant region in the nucleic acid isolation and purification market due to its strong biotechnology and pharmaceutical sectors, supported by robust research and development infrastructure.
- Furthermore, the presence of major market players and research institutions in South Africa fosters innovation and advancements in nucleic acid isolation and purification technologies.
- Additionally, High investment in genomic research and precision medicine contributes to the demand for advanced nucleic acid extraction and purification solutions in South Africa .
“South Africa is Projected to Register the Highest CAGR in Market”
- South Africa is projected to register strong growth in the nucleic acid isolation and purification market, driven by growing investments in biotechnology and life sciences research.
- Furthermore, the growing adoption of personalized medicine in South Africa , alongside the increasing demand for molecular diagnostics, is significantly contributing to market expansion. A surge in academic and clinical research activities, especially in genomics and precision medicine, is further driving the need for advanced nucleic acid isolation and purification technologies in South Africa .
- Additionally, the presence of emerging biotech startups and collaborations with established pharmaceutical companies are expected to foster further growth and innovation in South Africa 's nucleic acid isolation and purification market.
Nucleic Acid Isolation and Purification Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- Thermo Fisher Scientific Inc. (U.S.)
- Illumina Inc. (U.S.)
- PerkinElmer (U.S.)
- Meridian Bioscience, Inc. (U.S.)
- QIAGEN (South Africa )
- Takara Bio Inc. (Japan)
- MACHEREY-NAGEL GmbH & Co. KG (South Africa )
- Lepu Medical Technology (Beijing) Co., Ltd. (China)
- Merck KGaA (South Africa )
- Cytiva (Danaher Corporation) (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- KURABO INDUSTRIES LTD. (Japan)
- Analytik Jena GmbH+Co. KG (South Africa )
- TIANGEN BIOTECH (BEIJING) CO., LTD. (China)
Latest Developments in Nucleic Acid Isolation and Purification
- In April 2025, Analytik Jena has introduced a new 1536-tip tray for the CyBio Well vario, enabling parallel pipetting in 1536 channels with volumes ranging from 100 nL to 8 µL. This innovation, ideal for high-throughput applications, ensures high accuracy, minimal reagent consumption, and supports sustainable, reproducible laboratory workflows
- In March 2024, Analytik Jena has launched the multi N/C x300 series of TOC/TNb analyzers, offering user-friendly design, flexible automation, and intuitive software. Ideal for environmental and pharmaceutical applications, these analyzers ensure high throughput, reliability, and low operational costs, enabling efficient sample preparation, calibration, and maintenance with pharma-compliant data integrity
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR
5 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION
5.2 NORTH AMERICA REGULATORY SCENARIO
5.3 EUROPE REGULATORY SCENARIO
5.4 REGULATORY SUBMISSIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF GENETIC DISORDERS
6.1.2 INCREASING DEMAND FOR DIAGNOSTIC TESTING
6.1.3 RISING INVESTMENT IN GENOMICS RESEARCH
6.1.4 INCREASE IN LAUNCH OF DIAGNOSTIC PRODUCTS
6.2 RESTRAINTS
6.2.1 RISKS ASSOCIATED WITH SAMPLE CONTAMINATION
6.2.2 HIGH COST OF EQUIPMENT AND REAGENTS
6.3 OPPORTUNITIES
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION
6.3.2 INCREASING ADOPTION OF NEXT-GENERATION SEQUENCING (NGS)
6.3.3 GROWING APPLICATIONS OF LIQUID BIOPSY IN NON-INVASIVE DIAGNOSTICS
6.4 CHALLENGES
6.4.1 TECHNICAL DIFFICULTIES IN NUCLEIC ACID ISOLATION ACROSS DIFFERENT SAMPLE TYPES
6.4.2 ENVIRONMENTAL AND SUSTAINABILITY CONCERNS
7 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE
7.1 OVERVIEW
7.2 NEXT GENERATION SEQUENCING (NGS)
7.3 GENOMIC DNA ISOLATION AND PURIFICATION
7.4 TOTAL RNA ISOLATION AND PURIFICATION
7.5 PCR CLEAN-UP
7.6 PLASMID DNA ISOLATION AND PURIFICATION
7.7 MESSENGER RNA ISOLATION AND PURIFICATION
7.8 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
7.9 MICRORNA ISOLATION AND PURIFICATION
7.1 OTHERS
8 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 INSTRUMENTS
8.2.1 HOMOGENIZER
8.2.2 SPECTROPHOTOMETERS
8.2.3 FLUOROMETERS
8.2.4 OTHERS
8.2.4.1 BENCHTOP
8.2.4.2 STANDALONE
8.2.4.2.1 AUTOMATED
8.2.4.2.2 MANUAL
8.3 KITS
8.3.1 DNA ISOLATION & PURIFICATION KITS
8.3.2 RNA ISOLATION & PURIFICATION KITS
8.3.3 VIRAL NUCLEIC ACID ISOLATION KITS
8.3.4 PLASMID PURIFICATION KIT
8.3.5 PCR AND GEL KIT
8.3.6 OTHERS
8.3.6.1 MAGNETIC BEAD-BASED KIT
8.3.6.2 COLUMN-BASED KIT
8.3.6.3 REAGENT-BASED KIT
8.3.6.3.1 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT
8.3.6.3.2 PLANT DNA ISOLATION KIT
8.3.6.3.3 CELL-FREE TOTAL NUCLEIC ACID KIT
8.3.6.3.4 CELL-FREE DNA ISOLATION KIT
8.3.7 GENOMIC DNA PURIFICATION KIT
8.3.8 VIRAL RNA/DNA PURIFICATION KIT
8.3.9 PLANT DNA PURIFICATION KIT
8.3.10 MICROBIOME DNA PURIFICATION KIT
8.3.11 OTHERS
8.3.12 MAGNETIC BEAD-BASED KIT
8.3.13 COLUMN-BASED KIT
8.3.14 REAGENT-BASED KIT
8.3.15 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT
8.3.16 MRNA PURIFICATION KIT
8.3.17 PLANT RNA ISOLATION KIT
8.3.18 CELL-FREE NUCLEIC ACID ISOLATION KIT
8.3.19 OTHERS
8.3.20 RNA ISOLATION KIT
8.3.21 MI RNA ISOLATION KIT
8.3.22 VIRAL RNA/DNA KIT
8.3.23 MAGNETIC BEAD-BASED KITS
8.3.24 VIRAL SPIN-COLUMN KITS
8.4 REAGENTS
8.4.1 DNA ISOLATION REAGENT
8.4.2 RNA ISOLATION REAGENT
8.4.3 OTHERS
9 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE
9.1 OVERVIEW
9.2 FFPE SAMPLES
9.3 BLOOD CELLS
9.4 BACTERIA, YEAST, AND PLANTS
9.5 CELL-FREE SAMPLES
9.6 CULTURED CELLS
9.7 MAMMALIAN CELLS
9.8 BRAIN AND KIDNEY TISSUE
9.9 OTHERS
10 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD
10.1 OVERVIEW
10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
10.3 COLUMN -BASED ISOLATION AND PURIFICATION
10.4 REAGENT-BASED ISOLATION AND PURIFICATION
10.5 OTHERS
11 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 DIAGNOSTICS
11.2.1 INSTRUMENTS
11.2.2 KITS
11.2.3 REAGENTS
11.3 DRUG DISCOVERY AND DEVELOPMENT
11.3.1 INSTRUMENTS
11.3.2 KITS
11.3.3 REAGENTS
11.4 PERSONALIZED MEDICINE
11.4.1 INSTRUMENTS
11.4.2 KITS
11.4.3 REAGENTS
11.5 AGRICULTURE AND ANIMAL RESEARCH
11.5.1 INSTRUMENTS
11.5.2 KITS
11.5.3 REAGENTS
11.6 OTHERS
12 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS AND DIAGNOSTIC CENTERS
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.4 CONTRACT RESEARCH ORGANIZATIONS
12.5 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)
12.6 ACADEMIC/RESEARCH INSTITUTES
12.7 OTHERS
13 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 U.A.E.
13.1.4 QATAR
13.1.5 EGYPT
13.1.6 KUWAIT
13.1.7 BAHRAIN
13.1.8 OMAN
13.1.9 REST OF MIDDLE EAST AND AFRICA
14 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 MERCK KGAA
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 CYTIVA (DANAHER CORPORATION)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 AGILENT TECHNOLOGIES, INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 BIO-RAD LABORATORIES, INC.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 F. HOFFMANN-LA ROCHE LTD
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ANALYTIK JENA GMBH+CO. KG
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 AUTOGEN, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 DAAN GENE CO., LTD.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 HIMEDIA LABORATORIES
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 ILLUMINA, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 KURABO INDUSTRIES LTD.
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENT
16.13 LGC BIOSEARCH TECHNOLOGIES
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 MACHEREY-NAGEL GMBH & CO. KG
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 MAGGENOME TECHNOLOGIES PVT. LTD.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 MEDOX BIOTECH INDIA PVT. LTD.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 MERIDIAN BIOSCIENCE, INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 NEW ENGLAND BIOLABS
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 NORGEN BIOTEK CORP.
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 OMEGA BIO-TEK, INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 PCR BIOSYSTEMS
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 PERKINELMER
16.22.1 COMPANY SNAPSHOT
16.22.2 REVENUE ANALYSIS
16.22.3 PRODUCT PORTFOLIO
16.22.4 RECENT DEVELOPMENT
16.23 PROMEGA CORPORATION
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
16.24 QIAGEN
16.24.1 COMPANY SNAPSHOT
16.24.2 REVENUE ANALYSIS
16.24.3 PRODUCT PORTFOLIO
16.24.4 RECENT DEVELOPMENTS/NEWS
16.25 SAGE SCIENCE, INC.
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENTS
16.26 TAKARA BIO INC.
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENTS
16.27 THERMO FISHER SCIENTIFIC INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 REVENUE ANALYSIS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
16.28 TIANGEN BIOTECH (BEIJING) CO.,LTD.
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
16.29 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENT
16.3 ZYMO RESEARCH CORPORATION
16.30.1 COMPANY SNAPSHOT
16.30.2 PRODUCT PORTFOLIO
16.30.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 3 MIDDLE EAST AND AFRICA GENOMIC DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 4 MIDDLE EAST AND AFRICA TOTAL RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 5 MIDDLE EAST AND AFRICA PCR CLEAN-UP IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 MIDDLE EAST AND AFRICA PLASMID DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 7 MIDDLE EAST AND AFRICA MESSENGER RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 8 MIDDLE EAST AND AFRICA CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 9 MIDDLE EAST AND AFRICA MICRORNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 12 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 15 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 16 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 22 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 23 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 24 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 25 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 26 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 27 MIDDLE EAST AND AFRICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 29 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 30 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 31 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 33 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 34 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 36 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 37 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 40 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 41 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 42 MIDDLE EAST AND AFRICA FFPE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 43 MIDDLE EAST AND AFRICA BLOOD CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 44 MIDDLE EAST AND AFRICA BACTERIA, YEAST, AND PLANTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 45 MIDDLE EAST AND AFRICA CELL-FREE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 46 MIDDLE EAST AND AFRICA CULTURED CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 MIDDLE EAST AND AFRICA MAMMALIAN CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 MIDDLE EAST AND AFRICA BRAIN AND KIDNEY TISSUE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 49 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 51 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 52 MIDDLE EAST AND AFRICA COLUMN-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 53 MIDDLE EAST AND AFRICA REAGENT-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 54 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 55 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 56 MIDDLE EAST AND AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 57 MIDDLE EAST AND AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 58 MIDDLE EAST AND AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 59 MIDDLE EAST AND AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 60 MIDDLE EAST AND AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 61 MIDDLE EAST AND AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 MIDDLE EAST AND AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 63 MIDDLE EAST AND AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 65 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 66 MIDDLE EAST AND AFRICA HOSPITALS AND DIAGNOSTIC CENTERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 67 MIDDLE EAST AND AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 68 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 69 MIDDLE EAST AND AFRICA CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 70 MIDDLE EAST AND AFRICA ACADEMIC/RESEARCH INSTITUTES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 71 MIDDLE EAST AND AFRICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 72 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 73 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 74 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 76 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 77 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 78 MIDDLE EAST AND AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 79 MIDDLE EAST AND AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 MIDDLE EAST AND AFRICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 83 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 84 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 86 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 87 MIDDLE EAST AND AFRICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 90 MIDDLE EAST AND AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 91 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 92 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 93 MIDDLE EAST AND AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 94 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 96 MIDDLE EAST AND AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 97 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 98 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 99 MIDDLE EAST AND AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 100 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 101 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 102 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 103 MIDDLE EAST AND AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 104 MIDDLE EAST AND AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 MIDDLE EAST AND AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 MIDDLE EAST AND AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 109 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 110 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 112 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 113 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 114 SOUTH AFRICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 115 SOUTH AFRICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 SOUTH AFRICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 119 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 120 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 122 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 123 SOUTH AFRICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 126 SOUTH AFRICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 127 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 129 SOUTH AFRICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 130 SOUTH AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 SOUTH AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 132 SOUTH AFRICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 133 SOUTH AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 SOUTH AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 135 SOUTH AFRICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 136 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 137 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 139 SOUTH AFRICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 SOUTH AFRICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 SOUTH AFRICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 142 SOUTH AFRICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 143 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 145 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 146 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 148 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 149 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 150 SAUDI ARABIA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 151 SAUDI ARABIA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 152 SAUDI ARABIA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 155 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 156 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 158 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 159 SAUDI ARABIA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 160 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 162 SAUDI ARABIA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 163 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 165 SAUDI ARABIA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 166 SAUDI ARABIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 SAUDI ARABIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 168 SAUDI ARABIA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 169 SAUDI ARABIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 SAUDI ARABIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 171 SAUDI ARABIA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 172 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 173 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 175 SAUDI ARABIA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 SAUDI ARABIA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 SAUDI ARABIA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 SAUDI ARABIA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 180 SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 181 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 182 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 184 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 185 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 186 U.A.E. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 187 U.A.E. KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 U.A.E. DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 189 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 191 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 192 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 193 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 194 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 195 U.A.E. RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 198 U.A.E. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 199 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 200 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 201 U.A.E. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 202 U.A.E. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 U.A.E. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 204 U.A.E. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 205 U.A.E. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 206 U.A.E. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 207 U.A.E. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 208 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 209 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 210 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 211 U.A.E. DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 212 U.A.E. DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 U.A.E. PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 214 U.A.E. AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 U.A.E. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 217 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 218 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 220 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 221 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 222 QATAR INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 223 QATAR KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 224 QATAR DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 227 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 228 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 229 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 230 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 231 QATAR RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 232 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 233 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 234 QATAR MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 235 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 236 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 237 QATAR COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 238 QATAR VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 239 QATAR VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 240 QATAR VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 241 QATAR REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 QATAR REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 243 QATAR REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 244 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 245 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 246 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 247 QATAR DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 QATAR DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 249 QATAR PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 QATAR AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 251 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 QATAR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 253 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 254 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 256 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 257 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 258 EGYPT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 259 EGYPT KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 260 EGYPT DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 261 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 262 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 263 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 264 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 266 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 267 EGYPT RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 270 EGYPT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 271 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 273 EGYPT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 274 EGYPT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 275 EGYPT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 276 EGYPT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 277 EGYPT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 278 EGYPT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 279 EGYPT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 280 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 281 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 282 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 283 EGYPT DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 EGYPT DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 EGYPT PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 286 EGYPT AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 288 EGYPT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 289 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 290 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 291 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 292 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 293 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 294 KUWAIT INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 295 KUWAIT KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 296 KUWAIT DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 297 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 298 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 299 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 300 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 301 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 302 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 303 KUWAIT RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 305 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 306 KUWAIT MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 307 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 309 KUWAIT COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 310 KUWAIT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 KUWAIT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 312 KUWAIT VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 313 KUWAIT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 KUWAIT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 315 KUWAIT REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 316 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 317 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 319 KUWAIT DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 320 KUWAIT DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 KUWAIT PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 322 KUWAIT AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 323 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 KUWAIT NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 325 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 326 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 328 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 329 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 330 BAHRAIN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 331 BAHRAIN KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 332 BAHRAIN DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 333 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 334 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 335 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 336 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 338 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 339 BAHRAIN RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 340 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 341 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 342 BAHRAIN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 343 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 344 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 345 BAHRAIN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 346 BAHRAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 347 BAHRAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 348 BAHRAIN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 349 BAHRAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 350 BAHRAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 351 BAHRAIN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 352 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 353 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 354 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 355 BAHRAIN DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 BAHRAIN DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 BAHRAIN PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 358 BAHRAIN AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 359 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 BAHRAIN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 361 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 362 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 363 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 364 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 365 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 366 OMAN INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 367 OMAN KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 368 OMAN DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 369 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 371 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 372 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 373 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 374 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 375 OMAN RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 376 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 377 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 378 OMAN MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 379 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 380 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 381 OMAN COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 382 OMAN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 383 OMAN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 384 OMAN VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 385 OMAN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 386 OMAN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 387 OMAN REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 388 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 389 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 390 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 391 OMAN DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 392 OMAN DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 OMAN PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 394 OMAN AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 396 OMAN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 397 REST OF MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
List of Figure
FIGURE 1 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION
FIGURE 12 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 LINE CHART, BY PRODUCT (2024)
FIGURE 15 THREE SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2024)
FIGURE 16 INCREASING PREVALENCE OF GENETIC DISORDERS IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN THE FORECAST PERIOD (2025-2032)
FIGURE 17 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2025 & 2032
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
FIGURE 19 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY AGE GROUP (AGES 0–17)
FIGURE 20 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY GENDER
FIGURE 21 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY RACE AND ETHNICITY
FIGURE 22 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2024
FIGURE 23 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 24 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, CAGR (2025-2032)
FIGURE 25 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2024
FIGURE 27 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2025-2032 (USD THOUSAND)
FIGURE 28 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, CAGR (2025-2032)
FIGURE 29 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2024
FIGURE 31 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2025-2032 (USD THOUSAND)
FIGURE 32 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, CAGR (2025-2032)
FIGURE 33 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2024
FIGURE 35 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2025-2032 (USD THOUSAND)
FIGURE 36 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, CAGR (2025-2032)
FIGURE 37 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2024
FIGURE 39 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2025-2032 (USD THOUSAND)
FIGURE 40 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, CAGR (2025-2032)
FIGURE 41 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 42 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2024
FIGURE 43 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 44 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, CAGR (2025-2032)
FIGURE 45 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 46 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SNAPSHOT (2024)
FIGURE 47 MIDDLE EAST AND AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE 2024 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
